| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Founded by Dr. Samuel Brown, Brown Fertility is a fully comprehensive fertility clinic offering patients exceptional results through personalized care and affordable treatment plans. With over 15 years experience and the management of more than 5,000 IVF cycles, Dr. Samuel Brown consistently achieves success rates above the national average. From basic evaluation and testing to the most advanced procedures and treatments available, Brown Fertility is dedicated to Conceiving Miracles™.
Breathe California is a Daly City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prairie North Health Region is a North Battleford, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MAK Wood is a Grafton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.